Catalyst Wire Dossier Catalyst Wire Dossier

Desirudin

desirudin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Desirudin, covering 2011-06-13 to 2013-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis [Phase 4]

See pricing